[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.

Abstract

BACKGROUND Melanin-targeting radiotracers are interesting tools for imaging and treatment of pigmented melanoma metastases. However, variation of the pigment concentration may alter the efficiency of such targeting. OBJECTIVES A clear assessment of both tumor melanin status and dosimetry are therefore prerequisites for internal radiotherapy of disseminated melanoma. MATERIALS & METHODS The melanin tracer ICF01012 was labelled with iodine-123 for melanoma imaging in pigmented murine B16F0 and human SK-Mel 3 melanomas. RESULTS In vivo imaging showed that the uptake of [(123)I]ICF01012 to melanomas correlated significantly with melanin content. Schedule treatment of 3 × 25 MBq [(131)I]ICF01012 significantly reduced SK-Mel 3 tumor growth and significantly increased the median survival in treated mice. For this protocol, the calculated delivered dose was 53.2 Gy. CONCLUSION Radio-iodinated ICF01012 is a good candidate for both imaging and therapeutic purposes for patients with metastatic pigmented melanomas.

DOI: 10.1684/ejd.2014.2481

Cite this paper

@article{Viallard2015IICF01012MI, title={[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.}, author={Claire Viallard and Yann Perrot and Zied Boudhraa and Elodie Jouberton and {\'E}lisabeth Miot-Noirault and Mathilde Bonnet and Sophie Besse and Florence Mishellany and Anne Cayre and Lydia Maigne and Latifa Rbah-Vidal and Michel D'incan and Florent Cachin and Jean-Michel Chezal and Françoise Degoul}, journal={European journal of dermatology : EJD}, year={2015}, volume={25 1}, pages={29-35} }